Which GLP-1 medications have the highest and lowest risk of causing pancreatitis?
Summary
No summary yet. VIRAT can read this paper and write a plain-language summary of its aim, methods, key findings and limitations.
Summarise with VIRAT Free to try with your Science Catalogs account.Abstract
Current evidence indicates GLP-1 receptor agonists generally do not significantly increase the risk of pancreatitis, with no specific agent consistently identified as having the highest or lowest risk.
Fields of Study & Subjects
Diabetes Treatment and Management
Pancreatitis Pathology and Treatment
Pharmacovigilance and Adverse Drug Reactions
Publication details
- Journal / source
- Zenodo (CERN European Organization for Nuclear Research)
- Publication date
- 26 March 2026
- Language
- EN